Skip to main content

Prognostic Value of High Sensitivity C-Reactive Protein Among Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention


Patients with chronic kidney disease (CKD) are more likely to sustain adverse cardiac events following percutaneous coronary intervention (PCI). Inflammation is an important component of CKD and is associated with poor prognosis. Those with high residual inflammatory risk have increased risks of coronary events following PCI. Therefore, we investigated the impact baseline highsensitivity C-reactive protein (hsCRP) has on outcomes among CKD patients undergoing PCI.

Learn More